Tissue Engineering and Regenerative Medicine
Tissue Engineering and Regenerative Medicine is a research topic within Surgery. Science Explorer counts 42k research works in it since 1950. 23.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers revolves around the field of tissue engineering and regenerative medicine, with a focus on decellularization, extracellular matrix, organ engineering, bioartificial organs, and the development of scaffold materials for various tissue types. It also encompasses research on cardiac tissue engineering, biologic scaffolds, tissue-specific coatings, and the application of stem cell therapy in tissue regeneration.
- Decellularization
- Extracellular Matrix
- Organ Engineering
- Bioartificial Organs
- Regenerative Medicine
- Scaffold Materials
- Cardiac Tissue Engineering
- Biologic Scaffolds
- Tissue-Specific Coatings
- Stem Cell Therapy
- Research works
- 42k fractional, since 1950
- In the world top 10%
- 9.8k per year above
- Top-10% rate
- 23.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +5% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Tissue Engineering and Regenerative Medicine research?
By volume, China and the United States publish the most (1.6k and 1.5k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.6k works
- 2 United States 1.5k works
- 3 Japan 339 works
- 4 India 288 works
- 5 Germany 279 works
- 6 Iran 266 works
- 7 South Korea 229 works
- 8 United Kingdom 215 works
- 9 Italy 203 works
- 10 France 152 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Tissue Engineering and Regenerative Medicine research?
By volume in 2022–2025, Sichuan University publishes the most Tissue Engineering and Regenerative Medicine research, followed by Shanghai Jiao Tong University and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Sichuan UniversityChina 42 works
- 2 Shanghai Jiao Tong UniversityChina 28 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 26 works
- 4 Harvard UniversityUnited States 23 works
- 5 University of PittsburghUnited States 22 works
- 6 Kyoto UniversityJapan 22 works
- 7 Sun Yat-sen UniversityChina 21 works
- 8 Southern Medical UniversityChina 21 works
- 9 Stanford UniversityUnited States 21 works
- 10 Central South UniversityChina 19 works
Who are the leading researchers in Tissue Engineering and Regenerative Medicine?
The most-cited researchers publishing on Tissue Engineering and Regenerative Medicine include Manoj M. Lalu, Seeram Ramakrishna and Róbert Langer.
- 1 Manoj M. Lalu Canada 13k citations
- 2 Seeram Ramakrishna Singapore 5.1k citations
- 3 Róbert Langer United States 4.2k citations
- 4 William Wijns Belgium 3.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Tissue Engineering and Regenerative Medicine research done?
The largest centres of Tissue Engineering and Regenerative Medicine research in 2022–2025 are Beijing (China), Shanghai (China), Tehran (Iran) and Guangzhou (China).
Where is the best place to study Tissue Engineering and Regenerative Medicine?
Among universities, judged by research, Southern Medical University, Shahid Beheshti University of Medical Sciences and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Southern Medical UniversityChina | 66.2 | 48.1% | 8.9× | 21 | +24.9% |
| 2 | Shahid Beheshti University of Medical SciencesIran | 60.1 | 36.1% | 7.2× | 17 | +151.6% |
| 3 | Sichuan UniversityChina | 57.9 | 44.7% | 3.7× | 42 | +20.9% |
| 4 | Iran University of Medical SciencesIran | 57.9 | 27.3% | 7.8× | 14 | +806.6% |
| 5 | Tabriz University of Medical SciencesIran | 53.2 | 37.3% | 8.0× | 12 | — |
| 6 | Tehran University of Medical SciencesIran | 51.8 | 26.9% | 6.2× | 19 | +105.7% |
| 7 | Zhejiang UniversityChina | 46.6 | 47.4% | 1.4× | 19 | +52.2% |
| 8 | Air Force Medical UniversityChina | 46.5 | 37.9% | 8.9× | 10 | -46.6% |
| 9 | Shanghai Jiao Tong UniversityChina | 46.0 | 38.3% | 1.9× | 28 | +26.2% |
| 10 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 45.2 | 33.9% | 4.1× | 26 | -17.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Tissue Engineering and Regenerative Medicine research growing?
Output in 2018–2022 was 5% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Tissue Engineering and Regenerative Medicine.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.